Research map: Clinical phenotypes and disease outcomes of patients with systemic lupus erythematosus meeting indication for primary aldosteronism testing

Back to the article

Papers in this map

  1. Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus · M.C. Hochberg · 1997 · 11598 citations · Cited by this paper
  2. Unusual triad in systemic lupus erythematosus: Alopecia, pigmentation, and keratoderma · 2026 · Related
  3. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus · Michelle Petri · 2012 · 5391 citations · Cited by this paper
  4. Continuation of belimumab in patients with systemic lupus erythematosus in a real-world setting: A single-center retrospective cohort study · 2026 · Related
  5. The global epidemiology of hypertension · Katherine T. Mills · 2020 · 4240 citations · Cited by this paper
  6. Real-world use of anifrolumab in systemic lupus erythematosus: A retrospective study from a Danish tertiary center (2022–2025) · 2026 · Related
  7. The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline · John W. Funder · 2016 · 2963 citations · Cited by this paper
  8. Comparative study of adverse drug reactions associated with anifrolumab and belimumab for the treatment of systemic lupus erythematosus · 2026 · Related
  9. Combined Oral Contraceptives in Women with Systemic Lupus Erythematosus · Michelle Petri · 2005 · 1175 citations · Cited by this paper
  10. Frequency and clinical associations of Epstein-Barr virus molecular detection in systemic lupus erythematosus: A follow-up study · 2026 · Related
  11. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis · Silvia Monticone · 2017 · 1060 citations · Cited by this paper
  12. Association of GPX4 rs713041 and rs4807542 polymorphisms and serum GPX4 levels in Chinese patients with systemic lupus erythematosus · 2026 · Related
  13. Cardiovascular Outcomes in Patients With Primary Aldosteronism After Treatment · Cristiana Catena · 2008 · 565 citations · Cited by this paper
  14. Linear/arciform blaschkoid lupus erythematosus tumidus of the face – An extremely rare clinical manifestation · 2026 · Related
  15. Systemic lupus erythematosus · Alberta Yik-Bun Hoi · 2024 · 394 citations · Cited by this paper
  16. Factors associated with changes in self-efficacy in patients with systemic lupus erythematosus. Data from the almenara lupus cohort · 2026 · Related
  17. Cardiovascular disease in systemic lupus erythematosus: an update · Yudong Liu · 2018 · 167 citations · Cited by this paper
  18. Long-term outcomes of patients with moderate-severe pediatric systemic lupus erythematosus treated with combination rituximab and cyclophosphamide therapy: A single center cohort experience and review of literature · 2026 · Related
  19. High plasma leptin levels confer increased risk of atherosclerosis in women with systemic lupus erythematosus, and are associated with inflammatory oxidised lipids · Maureen A. McMahon · 2011 · 155 citations · Cited by this paper
  20. Serum C-reactive protein levels can predict organ damage in patients with SLE with the lupus low disease activity state · 2026 · Related
  21. Prevalence of and Factors Associated with Hypertension in Young and Old Women with Systemic Lupus Erythematosus · José Mario Sabio · 2011 · 115 citations · Cited by this paper
  22. Systemic lupus erythematosus and hypertension · Pamela Munguía‐Realpozo · 2019 · 94 citations · Cited by this paper
  23. Circulating Aldosterone and Natriuretic Peptides in the General Community · Alessia Buglioni · 2014 · 88 citations · Cited by this paper
  24. Outcomes of a Specialized Clinic on Rates of Investigation and Treatment of Primary Aldosteronism · Yuan-yuan Liu · 2021 · 85 citations · Cited by this paper
  25. High disease activity status suggests more severe disease and damage accrual in systemic lupus erythematosus · Rachel Koelmeyer · 2020 · 58 citations · Cited by this paper
  26. Rheumatoid factors in systemic lupus erythematosus: association with clinical and laboratory parameters · Torsten Witte · 2000 · 56 citations · Cited by this paper
  27. Primary Aldosteronism Screening Rates Differ with Sex, Race, and Comorbidities · Adina F. Turcu · 2022 · 52 citations · Cited by this paper
  28. The Australian Lupus Registry and Biobank: a timely initiative · Sean G O'Neill · 2017 · 46 citations · Cited by this paper
  29. Prevalence of metabolic syndrome in a cohort of systemic lupus erythematosus patients from Northeastern Brazil: association with disease activity, nephritis, smoking, and age · Marta Maria das Chagas Medeiros · 2015 · 45 citations · Cited by this paper
  30. How should lupus flares be measured? Deconstruction of the Safety of Estrogen in Lupus Erythematosus National Assessment–Systemic Lupus Erythematosus Disease Activity Index flare index · Aikaterini Thanou · 2014 · 43 citations · Cited by this paper
  31. Hydroxychloroquine treatment in a community‐based cohort of patients with systemic lupus erythematosus · Gabriela Schmajuk · 2010 · 41 citations · Cited by this paper
  32. Prevalence and correlation of conventional and lupus‐specific risk factors for cardiovascular disease in Chinese systemic lupus erythematosus patients · Liangle Yang · 2011 · 34 citations · Cited by this paper
  33. Increased Incidence of Resistant Hypertension in Patients With Systemic Lupus Erythematosus: A Retrospective Cohort Study · Jocelyn S. Gandelman · 2019 · 32 citations · Cited by this paper
  34. Adherence to consensus guidelines for screening of primary aldosteronism in an urban healthcare system · Maheshwaran Sivarajah · 2019 · 29 citations · Cited by this paper
  35. Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus · Fabien B. Vincent · 2020 · 27 citations · Cited by this paper
  36. Primary Aldosteronism in Chronic Kidney Disease: Blood Pressure Control and Kidney and Cardiovascular Outcomes After Surgical Versus Medical Management · Debbie L. Cohen · 2023 · 24 citations · Cited by this paper
  37. The lupus patient with positive rheumatoid factor · Aiessa Zanchett Fedrigo · 2018 · 23 citations · Cited by this paper
  38. Association of Hydroxychloroquine Use With Decreased Incident Atrial Fibrillation in Systemic Lupus Erythematosus · Alisha Gupta · 2020 · 23 citations · Cited by this paper
  39. Hydroxychloroquine and Cardiovascular Events in Patients With Systemic Lupus Erythematosus · Lamiae Grimaldi‐Bensouda · 2024 · 22 citations · Cited by this paper

Source: OpenAlex (CC0)